• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞死亡、治疗学与癌症中的免疫反应。

Cell death, therapeutics, and the immune response in cancer.

机构信息

Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Department of Breast Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

出版信息

Trends Cancer. 2023 May;9(5):381-396. doi: 10.1016/j.trecan.2023.02.001. Epub 2023 Feb 24.

DOI:10.1016/j.trecan.2023.02.001
PMID:36841748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10121860/
Abstract

Induction of cell death is inexorably linked with cancer therapy, but this can also initiate wound-healing processes that have been linked to cancer progression and therapeutic resistance. Here we describe the contribution of apoptosis and the lytic cell death pathways in the response to therapy (including chemotherapy and immunotherapy). We also discuss how necroptosis, pyroptosis, and ferroptosis function to promote tumor immunogenicity, along with emerging findings that these same forms of death can paradoxically contribute to immune suppression and tumor progression. Understanding the duality of cell death in cancer may allow for the development of therapeutics that shift the balance towards regression.

摘要

细胞死亡的诱导与癌症治疗是密不可分的,但这也可能引发与癌症进展和治疗耐药性相关的伤口愈合过程。在这里,我们描述了细胞凋亡和溶细胞死亡途径在治疗反应(包括化疗和免疫治疗)中的贡献。我们还讨论了细胞坏死、细胞焦亡和铁死亡如何促进肿瘤免疫原性,以及新发现这些相同的死亡形式可能矛盾地促进免疫抑制和肿瘤进展。了解癌症中细胞死亡的双重性可能有助于开发治疗方法,使平衡向消退方向转变。

相似文献

1
Cell death, therapeutics, and the immune response in cancer.细胞死亡、治疗学与癌症中的免疫反应。
Trends Cancer. 2023 May;9(5):381-396. doi: 10.1016/j.trecan.2023.02.001. Epub 2023 Feb 24.
2
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.针对癌症治疗的细胞死亡途径:细胞坏死、细胞焦亡、铁死亡和铜死亡研究的新进展。
J Hematol Oncol. 2022 Dec 8;15(1):174. doi: 10.1186/s13045-022-01392-3.
3
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.铁死亡、坏死性凋亡和细胞焦亡在抗肿瘤免疫中的作用。
J Hematol Oncol. 2020 Aug 10;13(1):110. doi: 10.1186/s13045-020-00946-7.
4
Ferroptosis, necroptosis, and pyroptosis in cancer: Crucial cell death types in radiotherapy and post-radiotherapy immune activation.铁死亡、坏死性凋亡和细胞焦亡在癌症中的作用:放疗及放疗后免疫激活中的关键细胞死亡类型。
Radiother Oncol. 2023 Jul;184:109689. doi: 10.1016/j.radonc.2023.109689. Epub 2023 May 6.
5
Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment.炎症相关的细胞焦亡,一种新的程序性细胞死亡途径,及其在癌症治疗中的免疫治疗的相互作用。
Theranostics. 2021 Aug 12;11(18):8813-8835. doi: 10.7150/thno.62521. eCollection 2021.
6
Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis.癌症治疗中靶向细胞死亡途径的选定黄酮醇:细胞凋亡、自噬、坏死性凋亡、焦亡、铁死亡和铜死亡研究的最新成果
Nutrients. 2024 Apr 18;16(8):1201. doi: 10.3390/nu16081201.
7
Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.肿瘤微环境中的铁死亡、坏死性凋亡和细胞焦亡:小细胞肺癌免疫治疗的新视角。
Semin Cancer Biol. 2022 Nov;86(Pt 3):273-285. doi: 10.1016/j.semcancer.2022.03.009. Epub 2022 Mar 12.
8
Programmed Cell Death Tunes Tumor Immunity.程序性细胞死亡调节肿瘤免疫。
Front Immunol. 2022 Mar 30;13:847345. doi: 10.3389/fimmu.2022.847345. eCollection 2022.
9
Programmed cell death in tumor immunity: mechanistic insights and clinical implications.肿瘤免疫中的程序性细胞死亡:机制见解与临床意义。
Front Immunol. 2024 Jan 12;14:1309635. doi: 10.3389/fimmu.2023.1309635. eCollection 2023.
10
Viral manipulation of host cell necroptosis and pyroptosis.病毒对宿主细胞坏死性凋亡和细胞焦亡的影响。
Trends Microbiol. 2022 Jun;30(6):593-605. doi: 10.1016/j.tim.2021.11.011. Epub 2021 Dec 18.

引用本文的文献

1
Programmed Cell Death in Cancer.癌症中的程序性细胞死亡
MedComm (2020). 2025 Aug 31;6(9):e70357. doi: 10.1002/mco2.70357. eCollection 2025 Sep.
2
Living on the Edge: ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target.边缘生存:癌细胞中的活性氧稳态及其作为治疗靶点的潜力
Antioxidants (Basel). 2025 Aug 16;14(8):1002. doi: 10.3390/antiox14081002.
3
The Effect of Polysaccharide Combined with Cisplatin on LLC1 Lung Cancer.多糖联合顺铂对LLC1肺癌的影响

本文引用的文献

1
Sublethal cytochrome c release generates drug-tolerant persister cells.亚致死细胞色素 c 释放产生药物耐受的休眠细胞。
Cell. 2022 Sep 1;185(18):3356-3374.e22. doi: 10.1016/j.cell.2022.07.025.
2
Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity.铁死亡导致的癌细胞死亡会抑制树突状细胞介导的抗肿瘤免疫。
Nat Commun. 2022 Jun 27;13(1):3676. doi: 10.1038/s41467-022-31218-2.
3
Inflammasomes in Cancer Progression and Anti-Tumor Immunity.炎症小体在癌症进展和抗肿瘤免疫中的作用
ACS Omega. 2025 Aug 5;10(32):35488-35496. doi: 10.1021/acsomega.4c11098. eCollection 2025 Aug 19.
4
A new era in cancer therapy: targeting the Proteasome-Bcl-2 axis.癌症治疗的新时代:靶向蛋白酶体 - Bcl - 2轴。
J Exp Clin Cancer Res. 2025 Aug 21;44(1):246. doi: 10.1186/s13046-025-03505-5.
5
PANoptosis in cancer: molecular mechanisms and therapeutic potential.癌症中的全程序死亡:分子机制与治疗潜力
Cancer Gene Ther. 2025 Aug 21. doi: 10.1038/s41417-025-00940-6.
6
Sulfasalazine induces ferroptosis in osteosarcomas by regulating Nrf2/SLC7A11/GPX4 signaling axis.柳氮磺胺吡啶通过调节Nrf2/SLC7A11/GPX4信号轴诱导骨肉瘤细胞发生铁死亡。
Sci Rep. 2025 Aug 18;15(1):30197. doi: 10.1038/s41598-025-13324-5.
7
Unveiling ammonia-induced cell death: a new frontier in clear cell renal cell carcinoma prognosis.揭示氨诱导的细胞死亡:透明细胞肾细胞癌预后的新前沿。
Front Immunol. 2025 Jul 31;16:1636977. doi: 10.3389/fimmu.2025.1636977. eCollection 2025.
8
Advances in cold atmospheric plasma therapy for cancer.冷大气等离子体癌症治疗的进展
Bioact Mater. 2025 Jul 25;53:433-458. doi: 10.1016/j.bioactmat.2025.07.031. eCollection 2025 Nov.
9
ESCO2 promotes the proliferation of hepatocellular carcinoma through the PI3K/AKT/ mTOR signaling pathway.ESCO2通过PI3K/AKT/mTOR信号通路促进肝细胞癌的增殖。
J Cancer. 2025 Jun 23;16(9):2929-2945. doi: 10.7150/jca.112087. eCollection 2025.
10
Cholesterol confers resistance to Apatinib-mediated ferroptosis in gastric cancer.胆固醇赋予胃癌对阿帕替尼介导的铁死亡的抗性。
Cell Biosci. 2025 Jul 4;15(1):95. doi: 10.1186/s13578-025-01435-5.
Front Cell Dev Biol. 2022 Apr 20;10:839041. doi: 10.3389/fcell.2022.839041. eCollection 2022.
4
CD8 T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4.CD8 T 细胞和脂肪酸通过 ACSL4 调控肿瘤铁死亡和免疫。
Cancer Cell. 2022 Apr 11;40(4):365-378.e6. doi: 10.1016/j.ccell.2022.02.003. Epub 2022 Feb 24.
5
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma.获得性抗丝裂原活化蛋白激酶(MAPK)靶向治疗耐药赋予黑色素瘤免疫逃逸的肿瘤微环境及对免疫治疗的交叉耐药性。
Nat Cancer. 2021 Jul;2(7):693-708. doi: 10.1038/s43018-021-00221-9. Epub 2021 Jul 15.
6
Impact of cancer cell-intrinsic features on neutrophil behavior.癌细胞内在特征对中性粒细胞行为的影响。
Semin Immunol. 2021 Oct;57:101546. doi: 10.1016/j.smim.2021.101546. Epub 2021 Dec 7.
7
Apoptotic stress-induced FGF signalling promotes non-cell autonomous resistance to cell death.凋亡应激诱导的成纤维细胞生长因子信号传导促进对细胞死亡的非细胞自主性抗性。
Nat Commun. 2021 Nov 12;12(1):6572. doi: 10.1038/s41467-021-26613-0.
8
Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity.肿瘤诱导内质网膜脂组成重排维持巨噬细胞存活和促肿瘤活性。
Nat Immunol. 2021 Nov;22(11):1403-1415. doi: 10.1038/s41590-021-01047-4. Epub 2021 Oct 22.
9
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs.使用BH3模拟物药物通过调控细胞凋亡进行癌症治疗
Nat Rev Cancer. 2022 Jan;22(1):45-64. doi: 10.1038/s41568-021-00407-4. Epub 2021 Oct 18.
10
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer.单细胞分析揭示了与三阴性乳腺癌对 PD-L1 阻断反应相关的关键免疫细胞亚群。
Cancer Cell. 2021 Dec 13;39(12):1578-1593.e8. doi: 10.1016/j.ccell.2021.09.010. Epub 2021 Oct 14.